Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies
Medication-related osteonecrosis of the jaw (MRONJ) is a major problem that can occur in people taking certain medications such bisphosphonates and denosumab. It can be used to treat osteoporosis or cancer. Bisphosphonate exposure, dental diseases and procedures, age, sex, anatomical factors, medica...
Saved in:
| Main Authors: | Raed AlRowis, Abdulmalik Aldawood, Mohammed AlOtaibi, Essam Alnasser, Ibrahim AlSaif, Abdullah Aljaber, Zuhair Natto |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2022-03-01
|
| Series: | Saudi Dental Journal |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1013905222000116 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ONJ (MRONJ) Update 2024: Osteonecrosis of the Jaw Related to Bisphosphonates and Other Drugs—Prevention, Diagnosis, Pharmacovigilance, Treatment—A National Italian Symposium
by: Vittorio Fusco, et al.
Published: (2025-04-01) -
Bisphosphonate-related osteonecrosis of the jaw: An enigma among medical practitioners
by: Shalini Krishnan, et al.
Published: (2019-01-01) -
Is medical therapy alone efficient for the management of Medication-related osteonecrosis of the jaw bones (MRONJ) in all stages?: a comparative single-center case-control study
by: Busehan Bilgin, et al.
Published: (2025-07-01) -
Systemic Ozone Therapy Improves Oral Hard and Soft Tissue Healing in Medication-Related Osteonecrosis of the Jaw (MRONJ): A Study in Senescent Female Rats
by: Leonardo Alan Delanora, et al.
Published: (2025-05-01) -
Denosumab Related Osteonecrosis of Jaw: a Case Report
by: Marco Vinícius de Sales Lima, et al.
Published: (2018-12-01)